ML 209
CAS No. 1334526-14-5
ML 209( —— )
Catalog No. M34963 CAS No. 1334526-14-5
ML-209 is an antagonist of retinoic acid receptor-related orphan receptor γt (RORγt; IC50= 1.1 μM in a reporter assay).1It inhibits RORγt-induced transcription in HEK293T cells expressing the human receptor (IC50= 300 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 141 | Get Quote |
|
| 5MG | 211 | Get Quote |
|
| 10MG | 275 | Get Quote |
|
| 25MG | 434 | Get Quote |
|
| 50MG | 632 | Get Quote |
|
| 100MG | 849 | Get Quote |
|
| 500MG | 1692 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameML 209
-
NoteResearch use only, not for human use.
-
Brief DescriptionML-209 is an antagonist of retinoic acid receptor-related orphan receptor γt (RORγt; IC50= 1.1 μM in a reporter assay).1It inhibits RORγt-induced transcription in HEK293T cells expressing the human receptor (IC50= 300 nM).
-
Description(±)-ML 209 (compound 4n), a diphenylpropanamide, is a retinoic acid-related orphan receptor RORγ antagonist with an IC50 of 1.1 μM. (±)-ML 209 inhibits RORγt transcriptional activity with an IC50 of 300 nM in HEK293t cells. (±)-ML 209 inhibits the transcriptional activity of RORγt, but not RORα in cells. (±)-ML 209 selectively inhibits murine Th17 cell differentiation without affecting the differentiation of na ve CD4+ T cells into other lineages, including Th1 and regulatory T cells.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayNuclear Receptor/Transcription Factor
-
TargetROR
-
RecptorROR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1334526-14-5
-
Formula Weight441.52
-
Molecular FormulaC25H31NO6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CC(=O)N1C[C@@H](C)C[C@@H](C)C1)(C2=C(OC)C=C(OC)C=C2O)C=3C=C4C(=CC3)OCO4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jun R Huh, et al. Identification of Potent and Selective Diphenylpropanamide RORγ Inhibitors. ACS Med Chem Lett. 2013 Jan 10;4(1):79-84. ?
molnova catalog
related products
-
XY018
XY018 is an orally available, selective and highly effective ROR-γ antagonist with antitumor activity, inhibits ROR-γ activity, inhibits tumor cell growth, and can be used to study drug-resistant prostate cancer.
-
Cedirogant
Cedirogant is an orally active retinoid-related orphan receptor-γt(RORγt) inverse agonist that is used for psoriasis study.
-
TMP-778
TMP-778 is a selective inverse agonist of RORγt.
Cart
sales@molnova.com